Table 2 HRs and 95% CIs for the associations of height (per 10 cm increase) with SCC and BCC risk
From: Height, height-related SNPs, and risk of non-melanoma skin cancer
NHS (Female) | HPFS (Male) | Meta-analysis | |||||
---|---|---|---|---|---|---|---|
HR (95% CI) | P -value | HR (95% CI) | P -value | HR (95% CI) | P -value | P for Heterogeneity | |
SCC | |||||||
Model 1 | 1.18 (1.09, 1.28) | <0.0001 | 1.18 (1.08, 1.28) | <0.0001 | 1.18 (1.11, 1.25) | <0.0001 | 0.99 |
Model 2 | 1.14 (1.06, 1.24) | 0.0009 | 1.16 (1.07, 1.26) | 0.0006 | 1.15 (1.09, 1.22) | <0.0001 | 0.80 |
Model 3 | 1.10 (1.02, 1.19) | 0.0198 | 1.10 (1.01, 1.21) | 0.0215 | 1.10 (1.04, 1.17) | 0.0011 | 0.92 |
Model 4 | 1.09 (1.00, 1.18) | 0.0429 | 1.09 (1.00, 1.18) | 0.0593 | 1.09 (1.02, 1.15) | 0.0057 | 0.99 |
BCC | |||||||
Model 1 | 1.18 (1.15, 1.20) | <0.0001 | 1.14 (1.11, 1.18) | <0.0001 | 1.16 (1.13, 1.20) | <0.0001 | 0.10 |
Model 2 | 1.16 (1.13, 1.18) | <0.0001 | 1.13 (1.09, 1.16) | <0.0001 | 1.14 (1.12, 1.18) | <0.0001 | 0.16 |
Model 3 | 1.12 (1.10, 1.15) | <0.0001 | 1.10 (1.07, 1.13) | <0.0001 | 1.11 (1.09, 1.13) | <0.0001 | 0.28 |
Model 4 | 1.11 (1.09, 1.14) | <0.0001 | 1.08 (1.05, 1.12) | <0.0001 | 1.10 (1.07, 1.13) | <0.0001 | 0.20 |